Download MendeleyThe structure of MadC from Clostridium maddingley reveals new insights into class I lanthipeptide cyclases.
Knospe, C.V., Kamel, M., Spitz, O., Hoeppner, A., Galle, S., Reiners, J., Kedrov, A., Smits, S.H.J., Schmitt, L.(2022) Front Microbiol 13: 1057217-1057217
- PubMed: 36741885 Search on PubMedSearch on PubMed Central
- DOI: https://doi.org/10.3389/fmicb.2022.1057217
- Primary Citation Related Structures:
8BYK - PubMed Abstract:
The rapid emergence of microbial multi-resistance against antibiotics has led to intense search for alternatives. One of these alternatives are ribosomally synthesized and post-translationally modified peptides (RiPPs), especially lantibiotics. They are active in a low nanomolar range and their high stability is due to the presence of characteristic (methyl-) lanthionine rings, which makes them promising candidates as bacteriocides. However, innate resistance against lantibiotics exists in nature, emphasizing the need for artificial or tailor-made lantibiotics. Obviously, such an approach requires an in-depth mechanistic understanding of the modification enzymes, which catalyze the formation of (methyl-)lanthionine rings. Here, we determined the structure of a class I cyclase (MadC), involved in the modification of maddinglicin (MadA) via X-ray crystallography at a resolution of 1.7 Å, revealing new insights about the structural composition of the catalytical site. These structural features and substrate binding were analyzed by mutational analyses of the leader peptide as well as of the cyclase, shedding light into the mode of action of MadC.
- Institute of Biochemistry, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Organizational Affiliation:
